Chen, Xiequn
85  results:
Search for persons X
?
1

Monitoring Minimal Residual Disease in Patients with Multip..:

Fan, Huishou ; Wang, Bing ; Shi, Lihui...
Clinical Cancer Research.  30 (2024)  6 - p. 1131-1142 , 2024
 
?
2

The evolution of preexisting primary immune thrombocytopeni..:

Fu, Haixia ; Cai, Xuan ; Cui, Lijuan...
Annals of Hematology.  103 (2024)  5 - p. 1549-1559 , 2024
 
?
 
?
10

P-211: Phase 2 MARCH study: ATG-010 plus Dexamethasone in C..:

Qiu, Lugui ; Fu, Weijun ; Fu, Chengcheng...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S155-S156 , 2021
 
?
11

P-192: Circularly permuted TRAIL (CPT) combined with Thalid..:

Chen, Wenming ; Xia, Zhongjun ; Fang, Baijun...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S143 , 2021
 
?
13

BRD4 inhibitor nitroxoline enhances the sensitivity of mult..:

Li, Guang ; Zheng, Yan-Hua ; Xu, Li...
Therapeutic Advances in Hematology.  11 (2020)  - p. 204062072093268 , 2020
 
?
14

First‐in‐patient study of hetrombopag in patients with chro..:

Wang, Zhenlei ; Chen, Li ; Zhang, Fengkui...
Journal of Thrombosis and Haemostasis.  18 (2020)  11 - p. 3053-3060 , 2020
 
?
15

Synergistic Efficacy of the Demethylation Agent Decitabine ..:

Jin, Yulong ; Xu, Li ; Wu, Xiaodong...
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.  27 (2019)  6 - p. 729-737 , 2019
 
1-15